Similar work using guinea pigs and the antithromboxane
agents imidazole, dipyradamole, and methimazole found
improved dermal perfusion in vivo and with India ink
injection studies when compared to controls, and suggested
a beneficial role in the reduction of Thromboxane A2 activity.